Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With CKD and Type 2 Diabetes

被引：0
|
作者：
Fu, Edouard [1 ,2 ]
D'Andrea, Elvira [1 ,2 ]
Wexler, Deborah J. [2 ,3 ]
Patorno, Elisabetta [1 ,2 ]
Paik, Julie M. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO260
引用
收藏
页码：673 / 673
页数：1
相关论文
共 50 条
  • [31] Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
    Zhang, Allan
    Kalil, Ramsey
    Marzec, Alexander
    Coulter, Stephanie A.
    Virani, Salim
    Patel, Kershaw V.
    Segar, Matthew W.
    TEXAS HEART INSTITUTE JOURNAL, 2024, 51 (01)
  • [32] Safety of sodium-glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations
    Davidson, Jaime A.
    Sukor, Norlela
    Hew, Fen-Lee
    Mohamed, Mafauzy
    Hussein, Zanariah
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (02) : 167 - 182
  • [33] Comparative safety of sodium-glucose cotransporter-2 (SGLT-2) inhibitors: Risk of hospitalization and cardiovascular events in patients with type 2 diabetes
    Mansour, Omar
    Chang, Hsien-Yen
    Alexander, G. Caleb
    Singh, Sonal
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 52 - 52
  • [34] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
    Anan, Go
    Kikuchi, Daisuke
    Hirose, Takuo
    Ito, Hiroki
    Nakayama, Shingo
    Mori, Takefumi
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 925 - 928
  • [35] Erythrocytosis induced by sodium-glucose cotransporter-2 inhibitors
    Chin-Yee, Benjamin
    Solh, Ziad
    Hsia, Cyrus
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (42) : E1271 - E1271
  • [36] Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
    Heerspink, Hiddo J. L.
    Kosiborod, Mikhail
    Inzucchi, Silvio E.
    Cherney, David Z. I.
    KIDNEY INTERNATIONAL, 2018, 94 (01) : 26 - 39
  • [37] Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy
    Rossing, Peter
    Filippatos, Gerasimos
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Chan, Juliana C. N.
    Kooy, Adriaan
    McCafferty, Kieran
    Schernthaner, Guntram
    Wanner, Christoph
    Joseph, Amer
    Scheerer, Markus F.
    Scott, Charlie
    Bakris, George L.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (01): : 36 - 45
  • [38] Sodium-glucose cotransporter-2 inhibitors: where and when?
    Cowie, Martin R.
    FUTURE CARDIOLOGY, 2020, 17 (03) : 403 - 406
  • [39] Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?
    Pafili, K.
    Papanas, N.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 693 - 695
  • [40] RE: Gout and sodium-glucose cotransporter-2 inhibitors
    Lund, Lars Christian
    Hojlund, Mikkel
    Henriksen, Daniel Pilsgaard
    Hallas, Jesper
    Kristensen, Kasper Bruun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 114 - 115
12345